How RxSugar’s PIM Investments Are Helping It Seize GLP-1 Opportunities

RxSugar products are available through 25,000 stores.

While the impact of GLP-1 medications on appetites has alarm bells ringing for some CPGs, many others view it as an opportunity to bite into. 

RxSugar is one such brand, and their earlier investments in product information management (PIM) are paying off as they ride an unexpected wave of increased demand. 

Founded in 2019, RxSugar aims to provide a healthier substitute for sugar through its line of plant-based snacks, syrups, and sugar alternatives. The company’s SKUs are available through drug, club, grocery, and mass channels, including CVS, Rite Aid, Costco, Kroger, Publix, and Walmart, among others.    

As a lean team of just six people, RxSugar’s vision of scaling to a wide network of retailers meant getting their arms around product content management, RxSugar founder and CEO Steven Hanley tells CGT. Each retailer can carry their own data and attribute requirements, and it only takes one bad product description to wreck a consumer’s perception of a nascent brand. 

Before GLP-1 was even a blip on most consumers’ minds, RxSugar expanded their partnership with 1WorldSync in 2020 in order to increase PIM accuracy. The CPG leverages the solution provider’s Data Loading & Maintenance solution, a decision that Hanley says has significantly enhanced processes. 

Because 1WorldSync can format, load, and publish RxSugar data more quickly and efficiently, the manufacturer has streamlined operations and enabled ongoing maintenance of product information across multiple retail channels. The platform’s attribution, full hierarchy support, and image-loading capabilities has reduced data loading process time by 50%, according to the exec.